Oncternal Therapeutics, Inc
5 clinical trials · Sponsor
◉ Watch Oncternal Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. (NCT05917470) | Oncternal Therapeutics, Inc | 2023-09-20 |
| A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies (NCT05588440) | Oncternal Therapeutics, Inc | 2023-05-09 |
| A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT05431179) | Oncternal Therapeutics, Inc | 2023-03-01 |
| A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies (NCT03088878) | Oncternal Therapeutics, Inc | 2018-01-03 |
Track Oncternal Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.